As a gamma-aminobutyric acid type A receptor agonist sevoflurane is a common
general anesthetic used in anesthesia and affects the neural development in
offspring. We hypothesized that sevoflurane could regulate interneurons via the
neuregulin-1-epidermal growth factor receptor-4 (NRG1–ErbB4) pathway in the
entorhinal cortex (ECT) of the middle pregnancy. Six female rats in middle
pregnancy (14.5 days of pregnancy) were randomly and equally divided into
sevoflurane (SeV) and control groups. The rats in the SeV group were
exposed to 4% sevoflurane for 3 hours. The expression levels of NRG1 and ErbB4,
parvalbumin (PV) and glutamic acid decarboxylase (GAD67), and
N-methyl-D-aspartate receptor subunit 2A (NR2A) and subunit 2B (NR2B) in
offspring were examined through immunohistochemistry. The pyramidal neurons in
the ECT were examined via Golgi staining. The levels of NRG1 and ErbB4 were
significantly decreased (P